Iron Deficiency Anemia Treatments

Find Iron Deficiency Anemia Treatments

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Iron Deficiency Anemia.

Found 4 Approved Drugs for Iron Deficiency Anemia

Venofer

Generic Name

Venofer

Generic Name

Venofer

Form: Injection

Method of administration: Intravenous, Intravitreal

FDA approval date: November 10, 2000

Classification: Parenteral Iron Replacement

Iron sucrose injection is indicated for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD). Iron sucrose injection is an iron replacement product indicated for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD). ( 1 )

Injectafer

Generic Name

Carboxymaltose

Injectafer

Generic Name

Carboxymaltose

Form: Injection

Method of administration: Intravenous

FDA approval date: August 12, 2013

Classification: Parenteral Iron Replacement

Injectafer is indicated for the treatment of: iron deficiency anemia (IDA) in: adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron. adult patients who have non-dialysis dependent chronic kidney disease., iron deficiency in adult patients with heart failure and New York Heart Association class II/III to improve exercise capacity. Injectafer is an iron replacement product indicated for the treatment of:, iron deficiency anemia (IDA) in: adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron. ( 1 ) adult patients who have non-dialysis dependent chronic kidney disease. ( 1 ), iron deficiency in adult patients with heart failure and New York Heart Association class II/III to improve exercise capacity. ( 1 )

Monoferric

Generic Name

Derisomaltose

Monoferric

Generic Name

Derisomaltose

Form: Injection

Method of administration: Intravenous

FDA approval date: January 16, 2020

Monoferric is indicated for the treatment of iron deficiency anemia (IDA) in adult patients: who have intolerance to oral iron or have had unsatisfactory response to oral iron who have non-hemodialysis dependent chronic kidney disease (NDD-CKD) MONOFERRIC is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients: who have intolerance to oral iron or have had unsatisfactory response to oral iron. ( 1 ) who have non-hemodialysis dependent chronic kidney disease. ( 1 )

Ferumoxytol

Brand Names

FeraBright, Feraheme

Ferumoxytol

Brand Names

FeraBright, Feraheme

Form: Injection

Method of administration: Intravenous

FDA approval date: July 13, 2009

Classification: Parenteral Iron Replacement

Feraheme is indicated for the treatment of iron deficiency anemia (IDA) in adult patients: who have intolerance to oral iron or have had unsatisfactory response to oral iron or, who have chronic kidney disease (CKD). Feraheme is an iron replacement product indicated for the treatment of iron deficiency anemia (IDA) in adult patients:, who have intolerance to oral iron or have had unsatisfactory response to oral iron ( 1 ) or, who have chronic kidney disease (CKD). ( 1 )

Showing 1-4 of 4

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances